Long circulating liposomes of 2′,3′-dideoxyinosine: Formulation and stability

References

• Allen T. M. Interaction of liposomes and other drug carriers with the mononuclear phagocyte system. Liposomes as Drug Carriers, G. Gregoriadis. Wiley, New York 1988; 37–50
   Google Scholar
• Allen T. M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 1987; 223: 42–46
   PubMed Web of Science ®Google Scholar
• Allen T. M., Hansen C., Rutledge J. Liposomes with prolonged circulation time: Factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta 1989; 981: 27–35
   PubMed Web of Science ®Google Scholar
• Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965; 13: 238–247
   PubMed Web of Science ®Google Scholar
• Betageri G. V. Liposomal encapsulation and stability of dideoxyinosine triphosphate. Drug Dev. Ind. Pharm. 1993; 19: 531–539
   Web of Science ®Google Scholar
• Betageri G. V., Parsons D. L. Drug encapsulation and release from multilamellar and unilamellar liposomes. Int. J. Pharm. 1992; 81: 235–241
   Web of Science ®Google Scholar
• Desormeaux A., Harvie P., Perron S., Makabi-Panzu B., Beauchamp D., Tremblay M., Poulin L., Bergeron M. G. Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2′,3′-dideoxyinosine. AIDS 1994; 8: 1545–1553
   PubMed Web of Science ®Google Scholar
• Dipali S. R., Kulkarni S. B., Betageri G. V. Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods. J. Pharm. Pharmacol 1996, in press
   PubMed Web of Science ®Google Scholar
• Doumon E., Rozenbaum W., Michon C., Perrone C., DeTruchis P., Bouvet E., Leracher M., Matheron S., Gharakhanian S., Girard P. M., Salmon D., Leport C., Dazza M. C., Regnier B. Effects of zidovudine in 365 consecutive patients with AIDS of AIDS-related complex. Lancet 1988; 2: 1297–1302
   PubMed Web of Science ®Google Scholar
• Elorza B., Elorza M. A., Sainz M. C., Chantres J. R. Comparison of particle size and encapsulation parameters of three liposomal preparations. J. Microencapsul. 1993a; 10: 237–248
   PubMed Web of Science ®Google Scholar
• Elorza B., Elorza M. A., Frutos G., Chantres J. R. Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: Study of drug release. Biochim. Biophys. Acta 1993b; 1153: 135–142
   PubMed Web of Science ®Google Scholar
• Gabizon A., Papahadjopoulos D. Liposome formulation with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 1988; 85: 6949–6953
   PubMed Web of Science ®Google Scholar
• Gill P. S., Rarick M., Brynes R. K., Causey D., Loureiro C., Levine A. M. zidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 1987a; 107: 502–505
   PubMed Web of Science ®Google Scholar
• Gottlieb M. S., Schroff R., Schanker H., Weisman J. D., Fan P. T., Wolf R. A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N. Engl. J. Med. 1981; 305: 1425–1431
   PubMed Web of Science ®Google Scholar
• Gregoriadis G., Davis C. Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem. Biophys. Res. Commun. 1979; 89: 1287–1293
   PubMed Web of Science ®Google Scholar
• Groopman J. E. Zidovudine intolerance. Rev. Infect. Dis. 1990; 12: S500–S506, Suppl. 5
   PubMedGoogle Scholar
• Kahn J. O., Lagakos S. W., Richman D. D., Cross A., Pettinelli C., Liou S. H., Brown M., Volberding P. A., Crumpacker C. S., Beall G. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N. Engl. J. Med. 1992a; 327: 581–587
   PubMed Web of Science ®Google Scholar
• Kahn J. O., Lagakos S. W., Richman D. D., Cross A., Pettinelli C., Liou S. H., Brown M., Volberding P. A., Crumpacker C. S., Beall G. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N. Engl. J. Med. 1992b; 327: 581–587
   PubMed Web of Science ®Google Scholar
• Kirby C., Gregoriadis G. The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vitro. Life Sci. 1980; 27: 2223–2230
   PubMed Web of Science ®Google Scholar
• Klecker R. W., Collins J. M., Yarchoan R., Thomas R., McAtee N., Broder S., Myers S. Pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS and related disorders. J. Clin. Pharmacol. 1988; 28: 837–842
   PubMed Web of Science ®Google Scholar
• Lasic D. D., Woodle M. C., Papahadjopoulos D. On the molecular mechanism of steric stabilization of liposomes in biological fluids. J. Liposome Res. 1992; 2: 335–353
   Google Scholar
• Lipsky J. J. Zalcitabine and didanosine. Lancet 1993; 341: 30–32
   PubMed Web of Science ®Google Scholar
• Litzinger D. C., Buiting A. M., Rooijen N. C., Huang L. Effects of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1994; 1190: 99–107
   PubMed Web of Science ®Google Scholar
• MacDonald R. C., MacDonald R. I. Application of freezing and thawing in liposome technology. Liposome Technology2nd ed., G. Gregoriadis. CRC Press, Boca Raton, FL 1993; Vol. I: 209–228
   Google Scholar
• Mayer L. D., Hope M. J., Cullis P. R., Janoff A. S. Solute distribution and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim. Biophys. Acta 1985; 817: 193–196
   PubMed Web of Science ®Google Scholar
• Mitsuya H., Broder S. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 1986; 83: 1911–1915
   PubMed Web of Science ®Google Scholar
• Mitsuya H., Weinhold K. J., Furman P. A., St Clair M. H., Nusinoff-Lehrman H., Gallo R. C., Bolognesi D., Barry D. W., Border S. 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T–lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA 1985; 82: 7096–7100
   PubMed Web of Science ®Google Scholar
• Morgan J. R., Williams K. E. Preparation and properties of liposome associated gentamicin. Antimicrob. Agents Chemother. 1980; 17: 544–548
   PubMed Web of Science ®Google Scholar
• Needham D., Hristova K., McIntosh T. J., Dewhirst M., Wu N., Lasic D. D. Polymer-grafted liposomes: Physical basis for the “stealth” property. J. Liposome Res. 1992; 2: 397–410
   Google Scholar
• New R. R. C. Introduction. Liposomes. A Practical Approach, R. R. C. New. Oxford University Press, OxfordUK 1989; 1–32
   Google Scholar
• Nohria A., Rubin R. H. Cytokines as potential vaccine adjuvants. Biotherapy 1994; 7: 261–269
   PubMedGoogle Scholar
• Onyeji C. O., Nightingale C. H., Marangos M. N. Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin. Infection 1994; 22: 338–342
   PubMed Web of Science ®Google Scholar
• Park J. W., Hong K., Carter E, Asgari H., Guo L. Y, Keller G. A., Wirth C., Shalaby R., Kotts C., Wood W. I. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA 1995; 92: 1327–1331
   PubMed Web of Science ®Google Scholar
• Phillips N. C., Skamene E., Tsoukas C. Liposomal encapsulation of 3′-azido-3′-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression. J. Acquir. Immune Defic. Syndr. 1991; 4: 959–966
   PubMed Web of Science ®Google Scholar
• Pidgeon C., McNeely S., Schmidt T., Johnson J. E. Multilayered vesicles prepared by reverse-phase evaporation: Liposomes structure and optimum solute entrapment. Biochemistry 1987; 26: 17–29
   PubMed Web of Science ®Google Scholar
• Richman D. D. Zidovudine resistance of human immunodeficiency virus. Rev. Infect. Dis. 1990; 12: 5507–5512, Suppl. 5
   Google Scholar
• Ryan P. J., Davis M. A., Melcior D. L. The preparation and characterization of liposomes containing X-ray contrast agents. Biochim. Biophys. Acta 1983; 756: 106–110
   PubMed Web of Science ®Google Scholar
• Scherphof G., Roerdink F., Waite M., Parks J. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim. Biophys. Acta. 1978; 542: 296–307
   PubMed Web of Science ®Google Scholar
• Seltzer S. E., Gregoriadis G., Dick R. Evaluation of the dehydration–rehydration method for production of contrast carry in liposomes. Invest. Radiol. 1988; 23: 131–138
   PubMed Web of Science ®Google Scholar
• Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1991; 1062: 77–82
   PubMed Web of Science ®Google Scholar
• Sunamoto J., Iwamoto K. Protein-coated and polysaccharide-coated liposomes as drug carriers. Crit. Rev. Ther. Drug Carrier Syst. 1986; 2: 117–136
   PubMedGoogle Scholar
• Szoka F., Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu. Rev. Biophys. Bioeng. 1980; 9: 467–508
   PubMedGoogle Scholar
• Taylor K. M., Taylor G., Kellaway I. W., Stevens J. Drug entrapment and release from multilamellar and reverse-phase evaporation liposomes. Int. J. Pharm. 1990; 58: 49–55
   Web of Science ®Google Scholar
• Torchilin V. P., Berdichersky V. R., Barsukor A. A., Smirnov V. N. Coating liposomes with proteins decreases their capture by macrophages. FEBS Lett. 1980; 111: 184–188
   PubMed Web of Science ®Google Scholar
• Walker W., Gallagher G. The in vivo production of human antibodies by vaccination of human-PBL-SCID mice. Immunology 1994; 83: 163–170
   PubMed Web of Science ®Google Scholar
• Washington C. Drug release from microdisperse systems: Critical review. Int. J. Pharm. 1990; 58: 1–12
   Web of Science ®Google Scholar
• Weiner N., Martin F., Riaz M. Liposomes as a drug delivery system. Drug Dev. Ind. Pharm. 1989; 15: 1523–1554
   Web of Science ®Google Scholar
• Yarchoan R., Mitsuya H., Myers C. E., Border S. Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N. Engl. J. Med. 1989; 321: 726–738
   PubMed Web of Science ®Google Scholar
• Zeisig R., Rudolf M., Eue I., Arndt D. Influence of hexadecylphos-phocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro. J. Cancer Res. Clin. Oncol. 1995; 121: 69–75
   PubMed Web of Science ®Google Scholar